Pharma's expensive gaming of the drug patent system is successfully countered by the Medicines Patent Pool, which increases global access and rewards innovation

The Medicines Patent Pool was created to promote public health, facilitating generic licensing for patented drugs that treat diseases predominantly affecting low- and middle-income countries.

Lucy Xiaolu Wang, Assistant Professor of Resource Economics, UMass Amherst • conversation
Dec. 5, 2022 • ~11 min

What’s in your medicine may surprise you – a call for greater transparency about inactive ingredients

There are ingredients in your pills other than the one designed to treat your ailments. Those unnamed ingredients can alter how you respond to a medicine or even make you sick.

Yelena Ionova, Postdoctoral Fellow in Quality of Medical Products, University of California, San Francisco • conversation
Sept. 11, 2020 • ~7 min

Medical supply chains are fragile in the best of times and COVID-19 will test their strength

Drug shortages occur regularly in the US, even in the best of times. The pharmaceutical supply chain embodies 'just in time' shipping and has little built-in redundancy.

Mark Daskin, Professor of Industrial and Operations Engineering, University of Michigan • conversation
March 25, 2020 • ~7 min

/

1